Mandate

EQT sells HemoCue to Quest Diagnostics Inc.

February 19, 2007

EQT has signed an agreement with Quest Diagnostics Inc. regarding the sale of HemoCue. HemoCue AB develops, manufactures and markets diagnostic systems for decentralized analyses at doctors' offices, health centres, hospital reception areas and various hospital wards.

Vinge acted as advisor to EQT during the sale. Representatives from Vinge included Fredrik von Baumgarten, Tuula Tallavaara, Ulrich Ziche, Fredrik von der Esch and Louis de Geer.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025